A Study On The Prevalence Of Amphetamine-Type-Stimulants (Ats) Use Among Primary And Private Methadone Maintenance Treatment (Mmt) Clients In Kuantan, Pahang by Mamat, Ruzmayuddin
A STUDY ON THE PREVALENCE OF 
AMPHETAMINE-TYPE-STIMULANTS (ATS) USE 
AMONG PRIMARY AND PRIVATE METHADONE 
















UNIVERSITI SAINS MALAYSIA 
2019 
A STUDY ON THE PREVALENCE OF 
AMPHETAMINE-TYPE-STIMULANTS (ATS) USE 
AMONG PRIMARY AND PRIVATE METHADONE 















Thesis submitted in fulfilment of the requirement  
for the degree of 








First and foremost, I would like to express my sincere gratitude to my supervisor 
Dr. Darshan Singh for his continuous support and guidance throughout my study at the 
Centre for Drug Research, Universiti Sains Malaysia.   
Nevertheless, I must express very profound gratitude to my mother for her support 
and prayer along my journey in this study. I would also like to thank my loved ones, who 
have supported me throughout my study. Despite going through numerous surgeries 
during my study, I would sincerely thank my wife and children who have tolerated, 
supported and motivated me to complete my studies. I would like to dedicate this thesis 
to my wife Nuratikah, and kids Ahmad Rafiuddin and Nuralina. 
Finally, I would also like to take this opportunity to thank all my colleagues and 
my senior pharmacist in Pejabat Kesihatan Daerah Kuantan for their kind cooperation 










TABLE OF CONTENTS 
Acknowledgement……………………………………………………………………....ii 
Table of Contents……………………………………………………………………....iii 
List of Tables………………………………………………………………….……...….x 
List of Figures…………………………………………………………………………..xi 




CHAPTER 1 - INTRODUCTION              1 
1.0 Introduction………………………………………………………………………1  
1.1 World Drug Abuse Problem……………………………………………………...1 
1.2       Malaysia Drug Abuse Problem…………………………………………………..4  
1.3       Methadone Maintenance Treatment (MMT) Program in Malaysia……………...7 
1.4 ATS Use Trends in Malaysia……………………………………………….........9  
1.5 Published Articles on Opiate Substitution Treatment (OST)  
in Malaysia……………………………………………………………………...11  
1.6 Research Problem………………………………………………………….........13 
1.7 Study Hypothesis………………………………………………………………..17 
1.8 Research Questions……………………………………………………………..18 
1.9 Research Objectives…………………………………………………………….18 
1.10 Scope of Study………………………………………………………………….19 
1.11 Significance of Research………………………………………………………..19 







CHAPTER 2 - LITERATURE REVIEW……………………………………..22
      
2.0 Introduction……………………………………………………………………..22 
2.1 Overview of the Global Illicit Drug Use Problem………………………………22 
2.2 Asian Drug Use Problem…………………………………………......................23 
2.3 Malaysia Drug Policy and Drug Abuse Problem………………….....................24 
2.4 Methadone Maintenance Treatment (MMT) Program in Malaysia.....................25 
2.5 Prevalence of HIV and Hepatitis C Infection in Drug Users in  
Malaysia………………………………………………………………………...26 
2.6 Addiction Definition………………………………………………....................28 
2.7 Drug Dependence………………………………………………….....................29 
2.7.1 Classification of Drug Dependence on DSM…………………………...29 
2.8 Types of Illicit Drugs and their Pharmacological Effects……….……………...30 
2.8.1 Opiate………………………………………………………...................31 
2.8.2 Pharmacology of Heroin………………………………………………..34 
2.8.3 Effect of Heroin………………………………………………………...34 
2.8.4 Heroin Route of Administration………………………………………...35 
2.8.5 Neural Mechanism of Opioid Withdrawal……………………………...35 
2.9 Amphetamine Type Stimulants…………………………………………………36 
 2.9.1 Pharmacology of ATS………………………………………………..…36 
 2.9.2 Pharmacokinetic of ATS………………………………………………..37 
 2.9.3 Clinical Effects of ATS Withdrawal…………………………………....38 
 2.9.4 Health Consequences Related to ATS Use and Injection……………....38 
 2.9.5 Amphetamine…………………………………………………………...39 
 2.9.6 Methamphetamine………………………………………………………40 
 2.9.7 Ecstasy (MDMA)………………………………………….....................41 
 2.9.8 Codeine…………………………………………………….....................41 
 2.9.9 Cocaine…………………………………………………….....................41 
 2.9.10 Cannabis………………………………………………………………...42 
 2.9.11 Ketamine………………………………………………………………..43 
 2.9.12 Benzodiazepines………………………………………………………...44 
v 
 
 2.9.13 Kratom…………………………………………………………………..45 
2.10 Pharmacological Treatments for Opiate Use Disorder…………….....................45 
 2.10.1 Opioid Antagonist…………………………………………....................46 
 2.10.2 Naltrexone…………………………………………………....................46 
 2.10.3 Opioid Agonist……………………………………………………….…47 
2.11 Methadone…………………………………………………………....................48 
 2.11.1 Pharmacology of Methadone……………………………………………48 
 2.11.2 Methadone Dose………………………………………………………...49 
 2.11.3 Methadone Side-Effects………………………………………………...50 
2.12 Buprenorphine…………………………………………………………………..50 




CHAPTER 3 - METHODOLOGY…………………………………………….53 
3.0 Introduction……………………………………………………………………..53 
3.1 Study Design……………………………………………………………………53 
3.2 Study Population………………………………………………………………..54 
3.3 Study Location………………………………………………………………….54 
3.4 Sample Size……………………………………………………………………..55 
3.5 Study Inclusion and Exclusion Criteria…………………………………………56 
3.6 Study Sampling…………………………………………………………………57 
3.7 Pilot-Study………………………………………………………………………57 
3.8 Data Collection Procedure and Study Questionnaire…………………………...58 
3.9 Urine Toxicology Screen………………………………………………………..61 
3.10 Data Analysis……………………………………………………………………61 
3.11 Ethics……………………………………………………………………………62 





CHAPTER 4 - RESULTS………………………………………………………64 
4.0 Introduction……………………………………………………………………..64 
4.1 Study Data Analysis…………………………………………………………….65 
4.2 Samples Socio-demographic Characteristics, Incarceration and Rehabilitation 
History and Infectious Diseases Status…………………………………………65 
4.2.1 Gender and Ethnicity…………………………………………………...65 
4.2.1 Current Age……………………………………………………………..65 
4.2.3 Marital Status…………………………………………………………...66 
4.2.4 Education Status………………………………………………………...66 
4.2.5 Employment and Income……………………………………………….66 
4.2.6 Accommodation………………………………………………………...67 
4.2.7 Previous Incarceration History………………………………………….67 
4.2.8 Previous Drug Rehabilitation History…………………………………..67 
4.2.9 Previous History of Mental Treatment………………………………….67 
4.2.10 ATS Treatment History…………………………………………………68 
4.2.11 HIV, Hepatitis C and Tuberculosis Status………………………………68 
4.3  Socio-demographic Characteristics and Illicit Drug Use History of Between  
Short and Long-Term Methadone Users………………………………………..68 
 
4.3.1 Summary of the Samples Socio-demographic 
Characteristics…………………………………………………………..73 
 
4.4    Current and Previous Illicit Drug Use History………………………………….73 
4.4.1  ATS Use History………………………………………………………..74 
4.4.2  Opiate Use History……………………………………………………...74 
4.4.3 Methamphetamine Use History………………………………………...74 
4.4.4 Amphetamine Use History……………………………………………...75 
4.4.5 Cannabis Use History…………………………………………………...75 
vii 
 
4.4.6 Benzodiazepine Use History……………………………………………75 
4.4.7 Alcohol Use History……………………………………………………76 
4.4.8 Ketum Use History……………………………………………………..76 
4.4.9 Ketamine Use History ………………………………………………….76 
4.5 Methadone Treatment History………………………………………………….79 
4.5.1 Methadone Duration, Dose and Treatment Satisfaction………………..79 
4.5.2 Urine Toxicology Screen……………………………………………….80 
4.5.3 Frequency of Methadone Use in the Last 7 Days………………………81 
4.6 ATS Use Reasons……………………………………………………………….82 
4.7 Psychological Problems………………………………………………………....83 
4.8 ATS Dependence Severity……………………………………………………...84 
4.9 Prevalence of Illicit Drug Use in Primary and Private  
MMT Attendees…………………………………………………………………85 
 
4.10 Prevalence of Illicit Drug Use with Methadone Dose……………………….….87 
4.11 HIV Risk Behaviors of Opiate Poly-Drug Users and ATS  
Users Only………………………………………………………………………90 
 
4.12 Treatment Satisfaction and Risky HIV Behaviors among  
Primary and Private MMT Attendees …………………………………………..94 
 
4.13 Summary of Study Findings…………………………………………………….95 
4.14 Conclusion………………………………………………………………………96 
 
CHAPTER 5 - DISCUSSION………………………………………………….97 
5.0 Introduction……………………………………………………………………..97 
5.1 Discussion Chapter Outline…………………………………………………….97 
5.2 Samples Socio-Demographic Characteristic……………………………………98 
viii 
 
5.2.1 Demographic Characteristics of Short and  
Long Term MMT Users……………………………………………….101 
  
5.2.2 Current and Previous Illicit Drug Use History………………………...103
  
5.2.3 Methadone Treatment History…………………………………………106 
5.2.4 ATS Use Reasons……………………………………………………...110 
5.2.5 Psychological Problems and ATS Dependence Severity……………..111 
5.3 Prevalence and Route of Illicit Drug Use between Primary  
and Private MMT Clients……………………………………………………..113 
 
5.4 Significance of Methadone Dosing……………………………………………115 
5.5  HIV Risk Behaviors…………………………………………………………...119 
5.6  Treatment Satisfaction, Illicit Drug Use and HIV Risk Behaviours     
       between Primary and Private MMT Attendees……………………………….121 
 
5.7  Conclusion……………………………………………………………………123 
 
CHAPTER 6 - CONCLUSION………………………………………………124 
6.0 Introduction……………………………………………………………………124 
6.1  Summary of Study Results……………………………………………………125 
6.2  Study Implications……………………………………………………………126 
6.3  Study Limitation………………………………………………………………128 
6.4  Suggestion for Future Research………………………………………………129 







REFERENCES         131 
APPENDICES 






LIST OF TABLES 
Page 
Table 1.0 Total arrests under DDA 1952 between 2013 to 2017…………………..6 
Table 2.0 Total number of drug users detected from 2013 to 2017………………..6 
Table 3.0 Total number of people arrested under Section 15 (1)(a) of  the  
DDA 1952 from 2013 to 2017…………………………………………..7 
 
Table 4.0 Comparison in opiate and ATS use from 2013 to 2017…………………7 
 
Table 5.0 Types of Opiates Receptor and Effect of Activation…………………...33 
. 
Table 6.0 Respondents Socio-demographic Characteristic (n=237)……………...70 
 
Table 7.0 Socio-demographic Characteristic and Illicit     
  Drug Use History of between Short and Long-Term User (n=237)……72 
 
Table 8.0 Respondents Current and Previous Illicit Drug Use History…………...77 
 
Table 9.0 Methadone Treatment History………………………………………….80 
 
Table 10.0 Prevalence of Illicit Drug Use among Clients in Primary and   
Private MMT Programs (n=237)……………………………………….86 
 
Table 11.0 Methadone dose and prevalence of illicit drug use among    
clients prescribed with ≤50mg and >51mg of methadone dose  
(n=237). ………………………………………………………………...89 
 
Table 12.0 Risky HIV Behaviours of opiate poly-drug users and ATS   
users only (n=237). …………………………………………………….92 
 
Table 13.0 Treatment satisfaction and HIV risk behaviours of clients    





LIST OF FIGURES 
Page  
Figure 1.0 Global trends in estimated number of drug users (2006-2015)……. 2 
Figure 2.0 Global trends in the estimated prevalence of people with 
drug use problem (2006-2015)……………………………………...2 
   
Figure 3.0 Number of Registered and Active Patient in Pahang……………….16 
 
Figure 4.0 Number of registered and Active Patient in Kuantan……………….16 
 
Figure 5.0 Random Drug Test in MMT Health Government Clinics from  
2014-2015………………………………………………………….. 17
             
Figure 6.0 Sample size of the respondents……………………………………. 56 
 
Figure 7.0 Urine Toxicology Screen…………………………………………... 81 
 
Figure 8.0 Frequency of Methadone Treatment in Last 7 Days………………..82  
 
Figure 9.0 ATS use Reasons…………………………………………………....83 
 
Figure 10.0 Psychological problems…………………………………………… 84 
 







LIST OF ABBREVIATIONS 
MMT   Methadone Maintenance Treatment Program. 
Primary  Patients registered in government MMT programs.  
Secondary  Patients registered in private MMT programs.  
ATS Amphetamine-types stimulant including methamphetamine and 
amphetamine 
BUP   Buprenorphine 
BZD   Benzodiazepine 
PWID   People who inject drugs 
FSW   Female sex worker 
MSM   Men who have sex with men 
OST   Opiate substitution therapy 
HIV   Human Immunodeficiency Virus 
Hep B   Hepatitis B 
HCV   Hepatitis C 
HAART  Highly active antiretroviral therapy  
SUD   Substance use disorder 
IDU   Injecting drug users 
UNODC                      United Nations of Office and Crime 
DDA   Dangerous Drug Act 
NADA   National Anti-Drug Agency 
SDG   Sustainable Development Goals 
QoL   Quality of Life 
CDDC   Compulsory Drug Detention Centers 
WHO   World Health Organization 
xiii 
 
HRWG  Harm Reduction Working Group 
FGD   Focus Group Discussion 
MOH   Ministry of Health 
LLPK   Langkah-langkah Pencegahan Khas 



















SATU KAJIAN TERHADAP PREVALENS PENGGUNAAN AMPHETAMINE-
TYPE-STIMULANTS (ATS) DIKALANGAN KLIEN KERAJAAN DAN 
SWASTA DALAM RAWATAN TERAPI METADON (MMT) DI KUANTAN, 
PAHANG 
ABSTRAK 
Preskripsi dos metadon yang optimum adalah berkaitan dengan peningkatan 
dalam pematuhan rawatan. Penggunaan “amphetamine-type-stimulants” (ATS) 
(contohnya metamfetamin dan amfetamin) semasa program rawatan terapi metadon 
(MMT) adalah berkaitan dengan pematuhan rawatan yang rendah dan tingkahlaku 
berisiko HIV. Kajian ini bertujuan untuk mengkaji hubungan antara dos metadon dan 
prevalen penggunaan ATS dalam klien yang berdaftar dalam program MMT kerajaan dan 
swasta di Kuantan, Pahang. Sejumlah dua ratus tiga puluh tujuh (n=129 kerajaan dan 
n=108 swasta) pengguna metadon direkrut dari dua program MMT melalui pensampelan 
mudah untuk kajian keratan rentas ini. Tinjauan dijalankan melalui temubual bersemuka 
menggunakan borang soal selidik semi-berstruktur. Semua responden telah disaring untuk 
pengunaan dadah terlarang. Majoriti lelaki (97%, n= 230/237), hanya 7 adalah wanita, di 
mana kebanyakan adalah Melayu (96%, n=228/237). Separuh (50%, n=119/237) adalah 
berumur antara 18 hingga 37 tahun, 47% bujang (n=112/237) dan 83% (n=198/237) 
bekerja. Dua puluh sembilan peratus (n=70/237) mempunyai hepatitis C. Purata umur 
sampel yang menggunakan metadon kali pertama adalah 32.8 tahun, purata tempoh 
rawatan metadon adalah 48.86 bulan dan purata dos metadon adalah 52.78mg/harian. Dua 
pertiga (68%, n=161/237) mempunyai ≤4 tahun sejarah penggunaan metadon, manakala 
32% (n=76/237) telah menggunakan metadon >4 tahun. Lima puluh lima peratus 
xv 
 
(n=130/237) menerima ≤50mg dos metadon harian dan 45% (n=107/237) menerima 
>50mg/harian dos metadon. Satu pertiga (36%, n=86/237) menggunakan ATS antara 1-3 
hari dan 26% (n=61/237) menggunakan ATS >4 hari dalam 7 hari yang lepas. 
Kebanyakan melaporkan telah menggunakan amfetamin (58%, n=138/237), 
metamfetamin (44%, n=104/237), dan opiat (37%, n=87/237) dalam 30 hari yang lepas. 
Satu pertiga melaporkan menyuntik amfetamin (35%, n=83/237), diikuti oleh 
metamfetamin (27%, n=64/237), dan opiat (21%, n=51/237) dalam 30 hari yang lepas. 
ATS kebiasaannya digunakan untuk a) meningkatkan produktiviti kerja, b) meningkatkan 
tenaga, c) meningkatkan euforia dan d) mengurangkan kebergantungan kepada metadon. 
Keputusan daripada analisis Chi-square menunjukkan responden dalam program MMT 
swasta adalah lebih suka menggunakan opiat (OR: 4.3: 2.47-7.64; p<.0001) dan 
metamfetamin (OR: 1.7: 1.01-2.84; p<0.046) dalam 30 hari yang lepas, berbanding 
dengan responden di program MMT kerajaan. Begitu juga, dos metadon yang rendah 
(≤50mg/harian) berkait dengan penggunaan opiat (OR: 0.3: 0.19-0.59: p<0.001) dalam 30 
hari yang lepas, manakala dos metadon yang tinggi (>50mg/harian) dikaitankan dengan 
penyuntikan metamfetamin dalam 30 hari yang lepas (OR: 1.97: 1.01-3.82; p<0.044). 
Berbanding dengan kumpulan pengguna ATS sahaja, pengguna opiate poly-drug 
mempunyai peningkatan risiko untuk mempunyai >2 pasangan seks tidak tetap dalam 30 
hari yang lepas (OR: 12.86: 1.31-125.78; p<0.018), dan menggunakan ATS sebelum 
terlibat dengan hubungan seks (OR: 2.12: 1.18-3.79; p<0.011). Terutamanya, responden 
dalam program MMT swasta tidak berpuas hati dengan program MMT mereka (OR: 2.83: 
1.49-5.39; p<0.002) dan dos metadon (OR: 2.89: 1.61-5.21; p<0.001), daripada responden 
di program MMT kerajaan. Responden di program MMT swasta mempunyai 
xvi 
 
kebarangkalian yang tinggi untuk menerima dos metadon yang rendah (OR: 1.84: 1.09-
3.09; p<0.022). Memandangkan preskripsi dos metadon yang rendah (≤50mg/harian) 
dikaitkan dengan penggunaan dadah terlarang dan penyuntikan metamfetamin, intervensi 
pencegahan yang sesuai diperlukan dengan segera untuk menangani penggunaan ATS 


















A STUDY ON THE PREVALENCE OF AMPHETAMINE-TYPE-STIMULANTS (ATS) 
USE AMONG PRIMARY AND PRIVATE METHADONE MAINTENANCE 
TREATMENT (MMT) CLIENTS IN KUANTAN, PAHANG 
ABSTRACT 
Optimum prescription of methadone dose is associated with improved treatment 
compliance. The use of amphetamine-type-stimulants (ATS) (e.g. methamphetamine and 
amphetamine) during Methadone Maintenance Treatment (MMT) is associated with poor 
treatment compliance and risky HIV behaviours. This study aims to investigate the 
relationship between methadone dose and prevalence of ATS use among clients enrolled 
in primary and private MMT program in Kuantan, Pahang. A total of two hundred and 
thirty-seven (n=129 primary and n=108 private) methadone users were recruited from two 
MMT programs through convenience sampling for this cross-sectional study. The surveys 
were conducted through face-to-face interviews with a semi-structured questionnaire. All 
the respondents were screened for illicit drug use. Majority males (97%, n=230/237), only 
7 were females, while most were Malays (96%, n= 228/237). Half (50%, n=119/237) were 
between the age of 18 to 37 years, 47% single (n=112/237), and 83% (n=198/237) 
employed. Twenty-nine percent (n=70/237) had hepatitis C. The samples mean age of 
first methadone use was 32.8 years, mean duration of methadone treatment was 48.86 
months and average methadone dose was 52.78mg/daily. Two-thirds (68%, n=161/237) 
had ≤4 years methadone treatment history, while 32% (n=76/237) have used methadone 
>4 years. Fifty-five percent (n=130/237) received ≤50mg of methadone dose daily and 
45% (n=107/237) received >51mg/daily of methadone dose. One-third (36%, n=86/237) 
used ATS between 1-3 days and 26% (n=61/237) used ATS >4 days in the last 7 days. 
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Most self-reported to have used amphetamine (58%, n=138/237), methamphetamine 
(44%, n=104/237), and opiates (37%, n=87/237) in the last 30 days. One-third reported 
injecting amphetamine (35%, n=83/237), followed by methamphetamine (27%, 
n=64/237), and opiates (21%, n=51/237) in the last 30 days. ATS was commonly used to 
a) increase work productivity, b) enhance energy, c) intensify euphoria and d) reduce 
dependence on methadone. Results from Chi-square analysis showed respondents in 
private MMT program are more likely to use opiates (OR: 4.3: 2.47-7.64; p<.0001) and 
methamphetamine (OR: 1.7: 1.01-2.84; p<0.046) in the last 30 days, compared to 
respondents in primary MMT program. Similarly, low methadone dose (≤50mg/daily) 
was associated with opiate use in the last 30 days, while high methadone dose 
(>50mg/daily) was associated with methamphetamine injection in the last 30 days (OR: 
1.97; 1.01-3.82; p<0.044). Compared to ATS only user group, opiate poly-drug users have 
elevated risk of having >2 irregular sex partners in the last 30 days (OR: 12.86: 1.31-
125.78; p<0.018), and use ATS before engaging in sexual intercourse (OR: 2.12: 1.18-
3.79; p<0.011). Notably, respondents in private MMT program were dissatisfied with 
their MMT program (OR: 2.83: 1.49-5.39; p<0.001) and methadone dose (OR: 2.89: 1.61-
5.21; p<0.001) than respondents in primary MMT program. Respondents in private MMT 
program have higher odds of receiving low methadone dose (OR: 1.84: 1.09-3.09; 
p<0.022). Since low methadone prescription (≤50mg/daily) was associated with illicit 
drug use and methamphetamine injecting, proper preventive interventions are urgently 








This chapter introduces the first topic of the thesis. The world drug abuse problem 
(e.g. problem drug use, production and trafficking of illicit substances) and Malaysian 
drug abuse problem (e.g. number of illicit drug users and types of drug use), as well as 
findings from published articles on Methadone Maintenance Treatment (MMT) program 
in Malaysia are succinctly discussed in this chapter. Moreover, the research problem, 
study hypothesis, research questions and study objectives, scope of study and research 
significance are clearly described in this chapter. 
1.1 World Drug Abuse Problem 
Figures from 2017 World Drug Report by United Nations Office on Drugs and 
Crime (UNODC) found despite the significant increase in the number of people who use 
drugs and prevalence of people who use drugs, the number of people with drug use 
disorders and prevalence of people with drug use disorders remains unchanged from 2006 
to 2016, See Figure 1 and Figure 2, (World Drug Report, 2017). It is estimated that a 
quarter of a billion people (aged 15-64 years) used drugs at least once in 2015 (range: 158-
351 million) (World Drug Report, 2017).  
2 
 
       
Figure 1.0 Global trends in estimated number of drug users (2006-2015).  
Figure 2.0 Global trends in the estimated prevalence of people with drug use problem 
(2006-2015).                                                                                  (Source: UNODC, 2017).  
 
Findings from the Global Burden of Disease Study 2015, estimated that around 17 
million “healthy” years of life lost (disability adjusted life years or DALYs) were 
attributable to drug use disorders in that year (World Drug Report, 2017). Opioid use is 
associated with the highest negative health impact, followed by amphetamine as the 
second most commonly abuse drug worldwide (with an estimated 35 million past-year 
users; range between 13 to 58 million), while methamphetamine is perceived to be widely 
used in most parts of Asia (World Drug Report, 2017). Globally, it was found that men 
are three times more predisposed than women to use amphetamine. Compared to men, 
women typically begin to use illicit substances later in life, but once they have initiated it, 
they tend to increase their rate of consumption more rapidly than men and may progress 
more quickly than men to the development of drug use disorder (World Drug Report, 
2017). In fact, many individuals with substance use disorders (SUDs) are not enrolled in 
treatment programs. According to UNODC, the number of people in treatment for 
disorders resulting from amphetamine use or ATS has been increasing in Asia, although 
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half of them are in treatment receiving treatment for opioid use disorders. In fact, about 
40%-80% of people enrolled in treatment for drug use disorders are diagnosed with poly-
drug use, this reflects the complexity of the current drug use phenomenon and challenges 
of treating people with drug use disorders effectively. Opioids (opiates, heroin and 
morphine) and amphetamine remains as the most widely consumed illicit substances 
globally, and its use is associated with a broad range of health consequences ranging from 
fatal to non-fatal overdose deaths, risk of acquiring infectious diseases (such as HIV or 
hepatitis C) through unsafe injecting practices, medical and psychiatric co-morbidities. 
According to UNODC, there are approximately 1 million injecting drug users in the world 
(UNODC, 2017). Findings from a meta-analysis by Mathers et al. (2010) showed IDUs 
particularly in Southeast Asia are prone to HIV and other blood-borne diseases such as 
hepatitis C, tuberculosis and sexually-transmitted diseases (STDs) due to the poor 
coverage of HIV prevention, treatment and care services for IDU population.  
Besides the health burden that is associated with illicit drug consumption, the 
seizure and production of illicit substances continued to increase globally. UNODC 
observed a double increased in the seizure of amphetamine and methamphetamine 
between 2010 and 2015. The increase in ATS seizures can be attributed to the improved 
access to alternative precursor chemicals and/or pre-precursors used in manufacturing 
ATS. In view of the established and expanding market for methamphetamine in East and 
South-East Asia, ATS markets continue to expand globally to North America, South-West 
Asia and in parts of Europe (World Drug Report, 2017). Methamphetamine dominates the 
global ATS market, while amphetamine is the main substance that has been reported to 
be widely used in Middle East, West and Central Europe. Seizure for ATS have increased 
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markedly from 93 tons in 2010, to 191 tons in 2015 (World Drug Report, 2017). Of which 
methamphetamine accounted for 61-80% of the total seizure. Similarly, as for opium 
poppy cultivation, UNODC estimated that the total global area under poppy cultivation in 
2016 was at 305,000 hectares, representing a 60% increase in cultivation size over the 
period of between 2010 and 2016. The increased in opium cultivation can be attributed to 
the rise in opium poppy cultivation in Afghanistan (World Drug Report, 2017). World 
Drug Report 2017 showed, methamphetamine use is spreading, while the number of 
individuals seeking treatment for methamphetamine use have increased. On the other 
hand, the emergence of New Psychoactive Substances (NPS) is also reported to be 
associated with various health problems. Unlike opioids, demand for NPS is growing since 
most NPS are currently not regulated and can be easily purchase from the dark net with 
limited legal consequences. Since NPS can mimic traditional drug effects, users are 
motivated to use NPS for various reasons including to search for an experience involving 
the paradigm of ‘modifying perceptions’, curiosity, sociability, search for energy or other 
functional expectations, boredom and peer-socialization (World Drug Report, 2017). 
Compared to traditional drugs, NPS can be easily acquired through the dark net (e.g. 
anonymous market place), it is often cheaper and sometimes better in potency. In fact, 
prisoners commonly use NPS, since most NPS cannot be detected through routine drug 
screen (World Drug Report, 2017).    
1.2 Malaysian Drug Abuse Problem 
Malaysia begin to experience problems with illicit drug use prior to pre-
independence when Chinese and Indian migrant workers were brought by the British to 
work in agricultural sectors in Malaya (Zurani et al., 2008). Indian laborer’s smoked 
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cannabis, while Chinese worker’s recreationally smoke opium to enhance work 
productivity and combat fatigue. Since opium and cannabis consumption was associated 
with drug dependence and dire health consequences, the use of narcotics was finally 
criminalized in Malaysia (Kamarudin, 2007). The drug abuse problem turned more serious 
when local Malay youths started using heroin in the late 70s. The emergence of heroin 
smoking or the “hippy culture” become popular during the Vietnam war when American 
soldiers introduced their heroin smoking norm during their visit to Malaysia. The drug 
abuse problem become more intractable due to the country’s close proximity with the 
porous borders of the ‘golden-triangle’ which prompted international drug syndicates to 
expand their drug trafficking routes. The use of psychotropic substances such as opiates 
(morphine/heroin) and amphetamine-type-stimulants (ATS) (meth/amphetamine) are 
currently regulated in Malaysia under the Dangerous Drugs Act (DDA) 1952. Those 
convicted for illicit drug trafficking and possession offences can be sent to the gallows. 
Latest figures from National Drug Report 2017 showed, the number of people arrested for 
drug related offences under DDA 1952, and the number of problem drug users (newly and 
repeat drug users) has increased in the country. For drug related arrests under DDA 1952, 
a marked increase was also recorded from 128,412 cases in 2013 to 158,386 cases in 2017 
(See Table 1.0). Similarly, the number of individuals arrested under LLPK 1985 (special 
preventive measures) have surged from 838 cases in 2013 to 1,237 cases in 2017 (See 
Table 1.0). In addition, a significant increase was also recorded in the number of drug 
users detected in the country between 2013 and 2017 (See Table 2.0). In addition, the 
number of newly detected cases of drug users continued to increase compared to repeat 
drug users in the country (See Table 2.0). While under Section 15(1)(a) of DDA 1952, the 
number of people arrested for illicit drug use particularly ATS have remained stable for 
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the last five years from 85,140 people in 2013 to 85,004 people in 2017 (See Table 3.0). 
Data from National Anti-drug Agency (NADA) also indicated that although opiate 
popularity remains high, ATS use especially methamphetamine is becoming more 
prevalent in the country (Annual Drug Report, 2017). Thus, it can be implied that 
methamphetamine use popularity is slowly surpassing opiate use prevalence among the 
newly detected drug users in the country (See Table 4.0).  
Table 1.0 Total arrests under DDA 1952 between 2013 to 2017.  
 




Others Total LLPK 
1985 
2013 4,301 9,533 114,578 128,412 838 
2014 4,923 11,282 115,607 131,812 949 
2015 5,354 13,080 122,504 140,938 854 
2016 5,771 15,427 132,006 153,204 1,019 
2017 6,759 17,723 133,904 158,386 1,237 
                                                                                      Source: Annual Drug Report, 2017.  
Table 2.0 Total number of drug users detected from 2013 to 2017. 
Years New drug users Repeat drug users Total 
2013 13,481 7,406 20,887 
2014 13,605 8,172 21,777 
2015 20,289 6,379 26,688 
2016 22,923 7,921 30,844 
2017 18,440 7,482 25,922 
                                                                                      Source: Annual Drug Report, 2017. 
 
Table 3.0 Total number of people arrested under Section 15 (1)(a) of the DDA 1952 from 
2013 to 2017.  
 
2013 2014 2015 2016 2017 
85,140 81,435 84,205 85,004 80,925 








Table 4.0 Comparison in opiate and ATS use from 2013 to 2017. 
 





2013 75.09% 13.58% 0.50% 1.73% 
2014 64.87% 18.42% 5.54% 2.39% 
2015 60.47% 29.60% 2.45% 2.31% 
2016 53.48% 31.82% 8.28% 2.41% 
2017 37.91% 38.89% 16.30% 2.85% 
                                                                                      Source: Annual Drug Report, 2017. 
 
1.3 Methadone Maintenane Treatment (MMT) Program in Malaysia 
In order to fulfil the Millennium Development Goal (MDG) pledge in halting HIV 
transmission in Malaysia, a Harm Reduction Working Group (HRWG) was established in 
January 2004 for the purpose of advocating the importance of implementing harm 
reduction initiatives, consisting of Needle Syringe Exchange Program (NSEP), provision 
of condom and methadone maintenance treatment (MMT) targeting People Who Use 
Drugs (PWUDs) (Devi et al., 2012). In October 2005, methadone maintenance treatment 
(MMT) program was finally launched. The MMT program was introduced in three-
phases; in phase one, MMT program was made available in hospitals, government health 
clinics and private clinics in four zones in peninsular Malaysia involving 1,240 clients. 
Findings from a pilot-study which was conducted in phase-one of MMT program 
implementation showed that there were no adverse events, in fact significant 
improvements in relationships with carers and work performances were noted with 
marked reduction in crime and high-risk behaviours (e.g. injecting and unprotected sex) 
during methadone use (Gill et al., 2007). As a result of the overwhelming treatment 
compliance rate or “retention rate” reaching almost 84% among MMT enrolees, the MMT 
program was eventually up-scale and made available in many government and private 
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health care facilities throughout Malaysia in the second-phase (Kaur et al., 2009). Since 
most opiate users were incarcerated and living with HIV, MMT was also made available 
in prison settings in the third-phase of MMT program implementation in 2008 
(Wickersham et al., 2013). During the initial pilot study, HIV infected prisoners in 
Pengkalan Chepa and Kajang prison were provided with methadone (Bachireddy et al., 
2011; Vijay et al., 2015).  
MMT is an Opiate Substitution Treatment (OST) program that is primarily 
designed to provide pharmacotherapy to opiate dependence (Faggiano et al., 2003). 
Methadone treatment is scientifically shown to have numerous benefits, especially in 
reducing opiate use, risky injecting behaviours, HIV and hepatitis C transmissions, opiate 
overdose deaths, recidivism, and etc. (Fei et al., 2016). In order to minimize HIV spread, 
MMT was finally implemented as an evidence-based harm reduction intervention in 
Malaysia (Ali et al., 2017). MMT program was solely introduced in Malaysia from a harm 
reduction standpoint and not as a security measure. Those seeking to abstain from illicit 
opiate use can enrol in both primary and private MMT programs in the country. After 
methadone was found to be helpful, the MMT program was eventually implemented in 
government and private health care clinics, as well as in Cure and Care (C&C) centres 
throughout the country (Ministry of Health, 2017). By December 2013, there was 
approximately 811 MMT centres (446 government facilities and 365 private settings) that 
provides treatment to about 65,259 opioid users (33,444 clients in government facilities 
and 31,805 in private settings) in the country.  However, only 18,600 clients were found 
the be active patients (Ali et al., 2017).  
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In Malaysia, opiate users have a choice to enrol in primary and private MMT 
programs. In private MMT program clients have to pay for their methadone treatment 
cost. In fact, those who have favourable treatment compliance history are also allow to 
buy ‘take-away’ methadone doses. While in primary or government clinics, clients can 
receive free methadone dose. However, not every patient is allowed to receive ‘take-away’ 
methadone dose. The program is only applicable to those who have good treatment 
compliance. Treatment compliance procedures could be a bit rigid in government MMT 
clinics compared to private MMT clinics. In government clinics, clients who are tested 
positive for illicit drug use can be automatically excluded from treatment. Nevertheless, 
compare to private MMT clients, clients in government MMT clinics have proper access 
to counselling, psychosocial interventions and medical services for their health problems 
such as HIV, Hepatitis C, tuberculosis, and mental health problems.  
Despite the availability of methadone treatment in private and primary settings, it 
is reported that clients in private MMT setting are more likely to have poor treatment 
compliance and predisposed to abuse illicit substances than clients in primary MMT 
setting (Vicknasingam et al., 2015). 
1.4 ATS Use Trends in Malaysia 
Based on the latest figures from National Anti-drug Agency (NADA), the number 
of people arrested for illicit drug consumption in the country has increased markedly from 
260,224 cases (between 2013 and 2014) to 452,528 cases (2015 to 2017) (Annual Drug 
Report, 2017). Though opiate use still remains as the main choice of drug widely abused 
in the country from 2010 to 2016, ATS use has surpassed opiate use in 2017 (Annual Drug 
Report, 2017). Findings from one of the earliest studies on ATS use was reported by 
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Chawarski et al. (2012). Chawarski and associates (2012) found a high number of out-of-
treatment opiate IDUs in Malaysia has significant risk of contracting HIV. Two factors 
were found to be associated with HIV infections; lifetime history of ATS use and lifetime 
history of sharing of injecting equipment. Out of the 732 respondents, 75% (n=551/732) 
had lifetime history of ATS use, and 23% (n=167) reported lifetime ATS injection drug 
use (Chawarski et al., 2012). This clearly indicates that opiate users in Malaysia are prone 
to abuse ATS or co-administer opiates with ATS. Similarly, Sulaiman et al. (2014) found 
co-morbid depressive disorder, bipolar disorder, antisocial personality disorder and heavy 
methamphetamine use were significantly associated with lifetime methamphetamine-
induced psychosis in methamphetamine users in Malaysia. Thus, it can be implied that 
chronic use of methamphetamine could adversely affect mental health. Moreover, besides 
the association of ATS use and mental health, a study by Chooi et al. (2017) found opiate 
users who reported initiating ATS use at a younger age are more likely to experience 
profound impairments in cognitive functioning. Desrosiers et al. (2016) conducted a focus 
group discussion among active drug users in rural areas of Kelantan and found drug users 
preferred using opiates concurrently with ATS at a younger age mainly due to peer 
influence, relieve boredom and cope with problems. Most of the respondents in the study 
claimed that they have limited knowledge about treatment options and perceived that there 
is no available treatment for ATS use. At present, those seeking treatment for ATS use 
problem can easily enrol in psychosocial programs under the care of National Antidrug 
Agency. Recently, Lim et al. (2018) found ATS use is also becoming more widespread 
among men having sex with men (MSM) in Malaysia. MSM in Malaysia used ATS to 
increase sexual capacity, heighten sexual pleasure and enhance sexual exploration and 
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adventurism. Despite engaging in risky behaviours, Lim et al. (2018) found MSM in 
Malaysia have limited access to sexual health and substance use treatment services.  
In summary, it can be deduced that ATS users in Malaysia are vulnerable to health 
problems and HIV risk behaviours.  
1.5 Published Articles on Opiate Substitution Treatment (OST) in Malaysia 
To fulfil the United Nations Sustainable Development Goals (SDGs) in halting HIV 
spread among opiate IDUs, Opiate Substitution (OST) Treatment or Methadone 
Maintenance Treatment (MMT) was eventually implemented in 2005 in Malaysia. OST 
or MMT was chiefly introduce to provide treatment access to people who use drugs 
(PWUDs) particularly illicit opiate users. Since the inception of MMT program, various 
studies have been conducted to determine the effectiveness of MMT program in the 
country. To date, there are about 13 published articles on MMT program in the country. 
Some of the earlier studies primarily looked at the quality of life (QoL) of MMT clients 
(Baharom et al., 2012; Devi et al., 2012). A study by Baharom et al. (2012) found clients 
enrolled in government MMT program have significant improvement in all domains (e.g. 
physical, psychological, social relationship and environment) of QoL after being on MMT 
program for at least six months. Similarly, a study by Devi et al. (2012) found opiate users 
enrolled in MMT program for a minimum of twelve-months have significant 
improvements in QoL, as most had refrain from heroin use, less likely to engage in HIV 
risk-taking behaviour and have better health outcomes. Recently, Ali et al. (2017) 
conducted a large cross-sectional study among clients enrolled in government MMT 
program in the country and found there were significant decrease in opiate use, HIV risk-
taking behaviour, involvement in criminal activity and improvement in QoL domains (e.g. 
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physical, psychological, social and environmental). In addition, Fei et al. (2016) found 
MMT program was effective in reducing heroin use, injecting practices and engagement 
in criminal activities, however methadone treatment did not seem to reduce client’s sex-
related HIV risk-taking behaviours over time.  
Nevertheless, a study by Vijay et al. (2015) found there are still sub-optimal levels 
of MMT experiences among people who injected drugs (PWIDs) in the country. Findings 
from the survey showed though treatment readiness for methadone treatment was 
moderately low, clients had more preference for methadone over buprenorphine treatment. 
Similarly, those who had moderately low treatment readiness scores have previous formal 
drug rehabilitation history. While those with higher treatment readiness scores was found 
to have past methadone treatment history, were older, have higher stress symptoms and 
engaged in needle/syringe sharing behaviours. It is not clearly known whether clients 
enrolled in primary MMT program are satisfied with their methadone program. Aziz and 
Chong, (2015) found a high percentage of clients enrolled in government MMT program 
was satisfied with their methadone treatment. However, majority of the respondents in the 
study highlighted that there is an urgent need for change particularly in dosing hours, 
waiting area and more manpower. Besides methadone treatment, opiate users in Malaysia 
can also access and seek buprenorphine treatment from private general practitioners. 
Buprenorphine treatment that comes in the form of tablet was eventually discontinued in 
Malaysia in 2006 when opiate IDUs started injecting buprenorphine. Due to the diversion 
issue, buprenorphine/naloxone combination was introduced in 2007. Despite the 
availability of buprenorphine/naloxone combination, Vicknasingam et al. (2010) found 
that there were no significant differences in the diversion and abuse occurrences of both 
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buprenorphine and buprenorphine/naloxone use among opiate IDUs in the country. After 
determining problems with buprenorphine diversion, findings from a large survey in 
Malaysia found low dispensing of buprenorphine/naloxone doses, lack of behavioural 
monitoring and counselling, high rates of continued drug use including injection of drugs 
with buprenorphine/naloxone were among some of the common problems related to OST 
program in the country (Vicknasingam et al., 2015). A study by Wickersham et al. (2013) 
found HIV positive prisoners who are given adequate methadone doses (≥80mg/daily) at 
the time of release had better retention on MMT program. Similarly, Bazazi et al. (2017) 
found providing methadone treatment to HIV positive opiate prisoners during 
incarceration has significant impact on their health. To gauge HIV infected prisoners’ 
attitude towards OST program, Bachireddy et al. (2011) found most incarcerated HIV 
positive opiate users expressed their interests to learn more about OST and believed OST 
is mainly needed to prevent relapse after their release from prison.  
Apart from these findings, findings related to ATS use among clients in MMT program 
remains scant and warrants further research. 
1.6 Research Problem 
Based on the current available findings, it is clearly shown that clients enrolled in 
methadone maintenance treatment (MMT) program in Malaysia are prone to use 
amphetamine-type-stimulants (ATS) (Vicknasingam et al., 2015). Despite the proven 
effectiveness of MMT program, treatment providers in primary MMT program continue 
to encounter various challenges ranging from illicit drug consumption problems to 
treatment compliance issues among treatment attendees (Ali et al., 2017). It is shown that 
low methadone dose or sub-therapeutic prescription of methadone dose is strongly 
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associated with illicit drug consumption among clients in MMT program (Faggiano et al., 
2003). Despite the incremental surged in ATS seizures (1,141.4kg in 2015 to 1,907.24kg 
in 2017) and drug related arrests under the Dangerous Drugs Act (DDA) 1952 (140,938 
in 2015 to 158,386 in 2017) (Annual Drug Report, 2017), the number of people detected 
for illicit drug use in the country have also substantially increased from 20,887 in 2013 to 
30,844 in 2016, though a slight decrease was observed in the number of problem drug 
users in 2017 (Annual Drug Report, 2017). Lately, National Antidrug Agency (NADA) 
personnel’s, found individuals with opiate use disorder in Compulsory Drug Detention 
Centres (CDDCs) have co-occurring opiate and ATS use disorders. On the other hand, 
treatment providers in primary (government) MMT clinics are beginning to see more 
newly registered methadone clients are being tested for opiate poly-drug use during their 
routine drug screens. Although, opiates have been widely used as the main choice of illicit 
drug between 2013 (75.09%) and 2015 (60.47%), however from 2016 onwards, ATS use 
have surpassed opiate use in the country. In fact, ATS use have outpaced opiate use among 
the newly detected drug users in the country in 2017 (Annual Drug Report, 2017). 
Moreover, the number of people arrested for drug consumption under Section 15(1)(a) of 
the DDA 1952 have remained constantly high since 2013 to 2017 (Annual Drug Report, 
2017).   
Despite the gradual increase in the number of individuals detected for ATS use in 
the country (31.82% in 2016 to 38.89% in 2017), at this juncture, there is no reliable 
evidence or studies to show whether clients in MMT program are vulnerable to ATS 
misuse during methadone treatment. Previous studies were mainly designed to investigate 
the quality of life (QoL) and prevalence of opiate use among MMT clients in Malaysia 
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(Ali et al., 2017). Findings from a recent large-scale study found although methadone 
users in Malaysia have significant improvements in various domains of QoL, 
unfortunately the samples average daily methadone dose was found to be low 
(54.8mg/daily) (Ali et al., 2018). Thus, perhaps the low dispensing of methadone doses 
could have propelled clients in MMT program to engage in ATS misuse. so far, no one 
have investigated the relationship between methadone dose and the prevalence of ATS 
use among treatment attendees in MMT program in the country.  
Preliminary findings from field work observations, as well as urine drug reports 
gathered from MMT clinics in the District of Kuantan, Pahang, showed clients in MMT 
programs are prone to misuse amphetamine-type-stimulants (ATS). Data obtained from 
government MMT clinics in Kuantan, Pahang, also showed that the number of opiate users 
seeking methadone treatment has increased. As of 2016, a cumulative total of 3,188 opiate 
users have registered in government-run MMT program in the State. However, out of this 
number, only 1,682 individuals were found to be active clients (Figure 1.5). While for the 
District of Kuantan, Pahang, a total of 670 opiate users have registered for methadone 
program, but only 285 respondents were found to be active methadone users (Figure 1.6). 
As for the random urine drug screens that was conducted between 2014 and 2015, majority 
were tested positive for ATS use compared to opiates, cannabis and benzodiazepine 
(Figure 1.7). The misuse of ATS during methadone treatment can affect treatment 
compliance and expose clients to HIV risk behaviours (Fei et al., 2016).   
Since data on ATS misuse among MMT clients are still limited, this study aims to 
determine the prevalence of ATS use among MMT attendees in both primary and private 
MMT programs in the District of Kuantan, Pahang. It is hoped that findings from this 
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preliminary study can help treatment providers to have a better understanding on the 
emergence of ATS misuse among clients in methadone treatment program, so that proper 
interventions can be develop to deter the misuse of ATS among MMT attendees in the 
country. 
Figure 3.0 Number of Registered and Active Patient in Pahang. 
 
 
                                                                                                   Source: MOH, Pahang.  
Figure 4.0 Number of registered and Active Patient in Kuantan. 
 
 






























































Figure 5.0 Random Drug Test in MMT Health Government Clinic from 2014 to 2015. 
 
 
                                                                                                           Source: MOH, Pahang.  
 
1.7 Study Hypothesis 
The study hypothesis includes; 
Low prescription of methadone dose is associated with amphetamine-type-
stimulants (ATS) misuse among MMT attendees in primary and private MMT programs 

















































1.8 Research Questions 
The research questions were specifically developed based on the study research problem.   
1. What is the socio-demographic and behavioural characteristics of ATS users in 
MMT programs in the District of Kuantan, Pahang?  
2. How prevalent is ATS use among MMT attendees in the District of Kuantan, 
Pahang? 
3. Is there a relationship between methadone dose and ATS use among MMT 
attendees in the District of Kuantan, Pahang?   
4. Does MMT attendees who self-reported opiate poly-drug use and ATS use engage 
in risky (sexual and injecting) HIV behaviours during MMT program in the 
District of Kuantan, Pahang? 
5. Are there any differences in treatment satisfaction, methadone dose and risky HIV 
behaviours of between primary and private MMT attendees in the District of 
Kuantan, Pahang? 
1.9 Research Objectives 
The study objectives are mainly formulated based on the research questions. The 
following are the study objectives;  
1. To identify the socio-demographic and behavioural characteristics of ATS users 
in MMT programs in the District of Kuantan, Pahang.  
2. To investigate the prevalence of ATS use among MMT attendees in the District 
of Kuantan, Pahang. 
3. To determine the relationship between methadone dose and ATS use among 
MMT attendees in the District of Kuantan, Pahang.  
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4. To analyse the HIV risk (sexual and injecting) behaviours of MMT attendees 
who self-reported opiate poly-drug use and ATS use in MMT programs in the 
District of Kuantan, Pahang.  
5. To investigate treatment satisfaction, methadone dose and risky HIV behaviours 
of between primary and private MMT attendees in the District of Kuantan, 
Pahang. 
1.10 Scope of Study 
The scope of study was to determine the prevalence of ATS misuse among 
treatment attendees in MMT programs in the District of Kuantan, Pahang. Those who self-
reported to be currently using ATS were recruited from two different MMT programs 
(primary vs. private MMT clinics) for the study. Respondents in this study were regular 
methadone users who were currently receiving methadone treatment for their opiate use 
disorder.  
1.11 Significance of Research 
This study is among the first to highlight about the emergence of ATS use among 
methadone users in primary and private MMT programs in the District of Kuantan, 
Pahang. The study findings have numerous policy significance. Most importantly, 
treatment providers (e.g. trained addiction specialists, private general practitioners, 
pharmacists, counsellors, etc.) can use this study findings to determine the motives and 
patterns of ATS use among methadone users. This in turn, could help treatment providers 
understand some of the key factors that is associated with ATS use among treatment 
attendees in MMT programs. Second, the study findings can be used to alert policy makers 
on the growing misuse of ATS among MMT clients in the country. Hence, this will enable 
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policy makers to design proper preventive interventions to curb ATS misuse among 
methadone users. In fact, certain guidelines can be drawn to exclude clients who are 
frequently tested for ATS use during routine urine drug screen. Nevertheless, policy 
makers could also determine some of the common factors that are associated with ATS 
use among clients in primary and private MMT programs. It will be interesting, with 
prospective studies can be conducted in other states to determine the severity of ATS use 
problem among MMT attendees in primary and private MMT programs in the country. In 
fact, future studies can use this study findings as a basis to develop proper research 
proposals. This in turn, could help researchers to look at broader issues related to the 
misuse of ATS use among MMT attendees in the country.  Last but not least, our findings 
can also be used to guide policy makers make informed-decisions pertaining to the 
occurrences of ATS misuse among methadone users in MMT programs in the country.  
1.12 Thesis presentation 
This thesis consists of six chapters. The first chapter is the introduction chapter. 
The world drug abuse problem and Malaysian drug abuse problem, history of methadone 
maintenance treatment (MMT) program, trends of ATS use in Malaysia are briefly 
described in this chapter. The importance of conducting the study is clearly delineated in 
the research problem section of this chapter. The study hypothesis, research questions and 
study objectives are clearly described in this chapter. In addition, the scope of study and 
research significance are also described in this chapter.    
The second chapter of the thesis is the literature chapter. All the relevant articles 
related to the scope of study are comprehensively analysed and described in this chapter.  
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The third chapter will provide detail explanation on the methods used in this study. 
The study design is discussed in this chapter. The study population, study location, 
inclusion and exclusion criteria, sampling procedure and data collection techniques is also 
described in this chapter. Procedures on how the urine toxicology screen was conducted 
among the study respondents were described in this chapter. Ethical issues, as well as 
compensation for taking part in the study is all described in this chapter. Finally, how the 
study data was analysed and interpreted was clearly explained in this chapter.  
Chapter four describes the study results. The study results are divided into sub-
sections based on the objectives of study. In the first part, the respondent’s socio-
demographic characteristics, methadone treatment history, illicit drug use history and 
current ATS use history are described.   
Chapter five is the discussion chapter where all the study results are analysed and 
discuss with various published articles. The format of discussion in this chapter is done 
sequentially according to the study objectives.  
The final chapter is the conclusion chapter. In this chapter, all the key findings of 
the study are summarized and concluded. The study implications and suggestions for 
future studies are also described in this chapter.  
1.13 Conclusion 
The next chapter is the study literature chapter. All the relevant articles related to 
the scope of study will be comprehensively analyse, compare and discuss in the literature 







This is the literature chapter. Relevant articles deemed suitable to the scope of 
study is delineated in this chapter. The literature chapter is divided into several sub-
sections. Information pertaining to the global illicit drug use problem, Asian drug use 
problem, Malaysia drug policy and drug use problem, Methadone Maintenance Treatment 
(MMT) program in Malaysia, HIV and hepatitis C situation, definition of addiction, drug 
dependence classification based on DSM-5, risky HIV behaviors, as well as types of illicit 
drugs and pharmacological treatment for opiate dependence are clearly explained in this 
chapter. 
2.1 Overview of the Global Illicit Drug Use Problem 
 Latest figures from World Drug Report (2017) by United Nations Office on Drugs 
and Crime (UNODC) estimated that there are approximately a quarter of billion people 
between the age of 15 to 64 years, who have used illicit substances at least once in 2015 
(range:158 to 351 million). Opioids were reported to cause the highest negative effects, 
while cannabis use remains as the most widely used substances (around 125 and 227 
million people is estimated to have used cannabis in 2015, equivalent to a prevalence rate 
of 3.8% of the adult population worldwide) around the globe (World Drug Report, 2017). 
Amphetamine-types-stimulants (ATS) were the second most widely abuse illicit drug in 
2015, where between 35 million people have used ATS, with a prevalence rate ranging 
from 0.5%-1.8% of the population aged 15-64 (World Drug Report, 2017). As for opiate 
misuse, about 42 to 58 million people are estimated to have used opiates in 2015, with a 
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prevalence rate of 0.9%-1.3% of the population aged 15-64 years (World Drug Report, 
2017). Recently, the used of New Psychoactive Substances (NPS) have begun the gain 
wider attention from regulatory, and health providers due to its deleterious effects. At the 
end of 2016, UNODC found there are about 664 types of NPS, in fact most are still not 
regulated, and can be easily purchased through the dark net (World Drug Report, 2017). 
NPS is popularly used as a safe substitute for illicit drugs, since most NPS cannot be 
detected through routine drug screen, and is reported to be non-harmful than traditional 
substances (World Drug Report, 2017).  
2.2 Asian Drug Use Problem 
 Asia is one of the largest opium production regions in the world. According to 
United Nations of Office on Drugs and Crime, Afghanistan and Myanmar were among 
the two largest opium-producing countries in the world (World Drug Report, 2017). The 
opium cultivation in Afghanistan have increased by 36% in 2013. Afghanistan recorded 
the highest (89%) opium production in 2013 (UNODC, 2015). While cannabis production 
remains borderless in most regions of the world (UNODC, 2015). Amphetamine-type-
stimulants (ATS) have become the main concern in Asia, when some regions in Asia 
became the major production and trafficking hub for ATS (64% of ATS seizures occurred 
in Asian regions) (UNODC, 2015). United Nations Office on Drugs and Crime estimated 
that more than half of the worlds ATS users resides in Asia (approximately 9.5 million 
methamphetamine users, and 3.9 million ecstasy users are situated in Asia). Countries like 
China, Cambodia, Singapore and Philippine recorded a marked increase in the use of 
methamphetamine (in the form crystalline) in 2015, while the use of methamphetamine 
tablets saw a significant surged in Thailand, Myanmar and Laos during the same period 
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(World Drug Report, 2017). At present, there is no data to show that large quantities of 
ATS are being manufactured in East and South-East Asia (World Drug Report, 2017).  
2.3 Malaysia Drug Policy and Drug Abuse Problem 
Malaysia have adopted a non-punitive approach in revamping the current drug 
policy which was deemed archaic and unsuitable with the present context. Previously, 
people with substance use disorder (SUD) were labelled as criminals, as the government 
believed that punitive drug laws or legislations can help address or curtail the illicit drug 
use problem in the country. Despite Malaysia’s tough stand against illicit drug use, those 
found guilty for consuming illicit substances and trafficking can be charged under the 
Dangerous Drugs Act 1952. At present, individuals with opiate dependence can be 
detained in Controlled Drug Detention Centres (CDDCs) for at least two-years, followed 
by another 2 years of community supervision after their post-released from CDDCs. 
During detention, inmates in CDDCs are required to undergo various recovery 
components which chiefly emphasized on psychosocial interventions like military type 
physical exercise, and spiritualism (Vicknasingam and Narayanan, 2008). Due to the 
exponential surged in HIV spread, non-government organizations such as IKHLAS begin 
to play a proactive role by urging the government to introduce harm-reduction 
interventions such as needle-syringe exchange program, and methadone treatment to cater 
to the treatment needs of out-of-treatment drug users in Malaysia (Malaysian AIDS 
Council, 2017). As a result of the constant request, a special working group was 
established in 2014, and named as the National Harm Reduction Working Group 
(HRWG). The group was tasked to reduce HIV spread, and drug use harms among drug 
users in the country. Harm reduction interventions were primarily introduced in Malaysia 
